Company news

Share this article:

IMS Health announced the launch of its IMS Precision Compensation offering to help pharmaceutical companies optimize their sales force incentive compensation programs and gain additional cost efficiencies. To deliver this new solution, IMS has established an alliance with Callidus Software, a leading provider of sales performance management software. “Pharmaceutical companies are looking for new ways to drive commercial excellence and realize cost efficiencies, especially in non-core areas of their businesses,” said Sati Sian, general manager, Sales Force Effectiveness, IMS.

Teva Specialty Pharmaceuticals, the US respiratory therapy unit of Teva Pharmaceutical Industries and UCB announced an agreement to co-commercialize Teva's US respiratory medicines. The initial product to be jointly promoted in the US is Teva's ProAir HFA (albuterol sulfate) inhalation aerosol. ProAir HFA is the number-one branded hydrofluroalkane (HFA) albuterol sulfate inhaler in the US. Additionally, the agreement will provide UCB future joint promotion opportunities with other products in development by Teva Specialty Pharmaceuticals. Financial terms of the agreement were not disclosed.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.